Agilent Technologies and A*STAR's Bioprocessing Technology Institute Collaborate on New Bioanalytical Methodologies

摘要

Agilent Technologies Inc. and the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, fechnology and Research (A*STAR) announced that they will collaborate on new analytical approaches to analysing specific protein-linked sugar compounds.The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyse minor glycan species.